Pages that link to "Q90481157"
Jump to navigation
Jump to search
The following pages link to Alexandra Barratt (Q90481157):
Displaying 32 items.
- Women's views on overdiagnosis in breast cancer screening: a qualitative study (Q30532790) (← links)
- The effect of information about overdetection of breast cancer on women's decision-making about mammography screening: study protocol for a randomised controlled trial (Q30578410) (← links)
- Model of outcomes of screening mammography: information to support informed choices (Q33937099) (← links)
- Overdetection in breast cancer screening: development and preliminary evaluation of a decision aid. (Q34264806) (← links)
- How different terminology for ductal carcinoma in situ impacts women's concern and treatment preferences: a randomised comparison within a national community survey. (Q36258712) (← links)
- Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review (Q36368845) (← links)
- Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography (Q36964358) (← links)
- Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review (Q37022468) (← links)
- Impact of extending screening mammography to older women Information to support informed choices (Q38702277) (← links)
- Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography (Q40077849) (← links)
- How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial (Q42376772) (← links)
- GPs want tailored, user friendly evidence summaries--a cross sectional study in New South Wales. (Q42639515) (← links)
- How do we achieve informed choice for women considering breast screening? (Q44060039) (← links)
- Expanding the evidence on cancer screening: the value of scientific, social and ethical perspectives (Q44148122) (← links)
- How different terminology for ductal carcinoma in situ (DCIS) impacts women's concern and management preferences: A qualitative study. (Q47645618) (← links)
- Carcinoma in situ of the breast in New South Wales, Australia: Current status and trends over the last 40 year (Q50204359) (← links)
- Estimates of overdiagnosis of invasive breast cancer associated with screening mammography (Q51138503) (← links)
- HPV testing versus repeat Pap testing for the management of a minor abnormal Pap smear: evaluation of a decision aid to support informed choice (Q56783286) (← links)
- Demonstration of Classic Screening Biases, Not Additional Benefit of Annual Over Biennial Screening (Q57056706) (← links)
- The importance of enabling informed decision making for women considering breast cancer screening (Q57188533) (← links)
- Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial (Q57188538) (← links)
- A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening (Q57274263) (← links)
- A randomized crossover trial of PAPNET for primary cervical screening (Q57391163) (← links)
- Liquid-based versus conventional cervical cytology – Authors' reply (Q57614647) (← links)
- Randomized trial of a self-administered decision aid for colorectal cancer screening (Q57746075) (← links)
- Reply to Braillon and Nicot (Q59731192) (← links)
- Overdiagnosis due to screening mammography for women aged 40 years and over (Q61822230) (← links)
- Overdiagnosis of lung cancer with low-dose computed tomography screening: meta-analysis of the randomised clinical trials (Q90481160) (← links)
- Impact of Full-Field Digital Mammography versus Film-Screen Mammography in Population Screening: a Meta-analysis (Q96642018) (← links)
- The potential for overdiagnosis and underdiagnosis because of blood pressure variability: a comparison of the 2017 ACC/AHA, 2018 ESC/ESH and 2019 NICE hypertension guidelines (Q98287556) (← links)
- Mammography screening for breast cancer-the UK Age trial (Q101353704) (← links)
- Alexandra Barratt (Q116486871) (← links)